Teladoc Health Inc buy Royal Bank of Canada
Start price
25.10.23
/
50%
€16.46
Target price
25.10.24
€28.38
Performance (%)
-48.21%
Price
25.07.24
€8.52
Summary
This prediction is currently active. Massive losses of -48.21% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 25.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | -0.281% | -0.281% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $35.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.29
26.04.24
26.04.24
€16.82
26.04.25
26.04.25
-30.64%
25.07.24
25.07.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€14.32
21.02.24
21.02.24
€23.12
21.02.25
21.02.25
-40.47%
25.07.24
25.07.24